Nestle India LtdNSE:NESTLEIND
Current view Q4 2026
Maggi-and-Nescafe giant just posted its best sales quarter in a decade, driven by selling more in small towns plus premium products. Steady record, but a new outsider CEO is unproven.
Latest exchange filings last 5 · 5 after Q4 2026
- 15 Sep ’26Nestlé India will participate in JP Morgan India Conference in Mumbai on 21 September 2026. ↗
- 9 Sep ’26Tamil Nadu GST appeal partially allowed; Rs. 1.30 crore tax, interest and Rs. 12.97 lakh penalty confirmed. ↗
- 31 Aug ’26Nestlé India held a one-on-one institutional investor meet in Mumbai; no UPSI was shared. ↗
- 27 Aug ’26Nestlé India will acquire 26% in Radiance KA for ₹7.61 crore to support captive renewable power. ↗
- 26 Aug ’26Customs order demands ₹11.11 crore duty, ₹25 lakh redemption fine, and ₹50 lakh penalty. ↗
Exchange filings, with the company's own one-line summary, read off the same page as the figures. Screener publishes only the most recent few, so this is the last 5 — not everything filed since your note, and a quiet-looking list is not proof of a quiet quarter. A filing is marked new when it is dated after the end of the quarter your note covers. Not scored, and not a judgement — a routine repayment notice and a takeover sit in the same list.
AI concall report · Q4 2026
The full earnings-call read behind this view — what management promised, what they delivered, and the earning trigger.
Growth Q4 2026
| Metric | This year vs lastYoY · vs Q4 2025 | vs the quarter beforeQoQ, sequential · vs Q3 2026 | 3-year yearly average3Y CAGR · compounded | 5-year yearly average5Y CAGR · compounded |
|---|---|---|---|---|
| Sales | ▲ +22.6% | +19.1% | +8.9% | +11.6% |
| Operating profit | ▲ +28.5% | +49.7% | +7.7% | +9.8% |
| EPS | ▲ +27.1% | +11.2% | +7.1% | +10.6% |
| PAT | ▲ +27.3% | +11.3% | — | — |
Tinted rows drive the Tier. Tier = the weaker of YoY Sales and YoY PAT growth. Here the weaker is Sales at +22.6%, which is ≥ 20% → Tier 1.
QoQ is sequential, not a trend. For most Indian companies the March quarter is seasonally the largest, so a June-quarter fall against it is a calendar effect. Only the YoY column feeds the Tier.
Multibagger potential
Average54/100
Growing, but too slowly to re-price. Profit per share grew 7% a year. A big re-pricing usually needs more than 15% a year, so the score is capped no matter how cheap it looks.
₹1,346 → ₹2,692 needs the P/E at 121× — it is 74× today, and has ranged 61× to 89× over the last 5 years. The rest would come from earnings growing as they have.
What you pay for its profitlog scale · 5-year range
Tripling needs 181× — never traded above 89× in 5 years.
Re-rated already, on growth that doesn't fully back it.
How this is calculated
This is arithmetic, not a forecast — Return = ΔEPS × ΔMultiple. It says what would have to be true, not how likely it is, and "earnings keep growing at this rate for three more years" is the assumption doing the most work. This is a mega-cap at ₹2,68,279 cr — size is the headwind here: a triple means the market finding ₹5,36,558 cr of new value.
Band capped: growth of 7.1% is below the 15% bar a re-rate needs.
Growth rate used: 7.1% — the weakest of EPS / Sales / Op-profit from 3-year EPS CAGR. Latest quarter reads 27%.
How it compares with its rivals FMCG · 6 of 27 listed
These are the industry's largest names rather than companies of its own size, so the columns are worth reading straight across — a ranking against them would only be restating the size gap.
| Company | Price | P/E | Size | ROCE | Profitlast qtr | Saleslast qtr |
|---|---|---|---|---|---|---|
| Nestle India | ₹1,342 | 69.8× | ₹2.59 L Cr | 85.3% | +49.0% | +25.2% |
| Britannia Inds. | ₹5,004 | 46.3× | ₹1.21 L Cr | 56.0% | +13.6% | +8.2% |
| Zydus Wellness | ₹519 | 74.5× | ₹16,516 Cr | 4.9% | −7.0% | +66.9% |
| Bikaji Foods | ₹552 | 49.9× | ₹13,837 Cr | 22.0% | +2.2% | +8.7% |
| The Bombay Burmah | ₹1,474 | 8.3× | ₹10,284 Cr | 33.0% | +17.5% | +8.0% |
| Mrs Bectors | ₹219 | 52.1× | ₹6,726 Cr | 12.9% | +41.8% | +15.7% |
Screener's own peer group, from the request already made for the industry P/E. It serves the industry's largest names by market cap, not companies of a similar size, so treat this as context rather than a like-for-like table; this company is always shown. On a phone the price, size and sales columns are dropped rather than pushed off the edge. Not part of the score.
Business quality to Jun 2026
| Are the margins widening? | broadly flat | operating margin 24% → 24% over 2.5 years |
|---|---|---|
| Did the profit turn into cash? | most of it arrived as cash | 116% last year, 98% over three · free cash flow ₹4,221 cr, positive in 3 of 3 years |
| Is the growth borrowed? | essentially debt-free | ₹444 cr — 0.09× its own equity (was 0.29×) |
| Is it being collected? | collection is steady | 5 days to collect, down 2 in a year · cash cycle −19 days |
| Who has been buying? | the promoters have held steady | promoters 62.8%, 62.8% → 62.8% over 2.8 years · FIIs 10.3% · DIIs 11.9% (+0.7) · shareholders 1,84,090 → 4,79,696 |
| What does it earn on its capital? | earns a high return on the capital it employs | ROCE 85.3% · ROE 74.2% |
Fetched from the filings, not typed — and deliberately not part of the score. These are the questions the score cannot ask: it reads growth, price and trend, so a company can score well while its profit never becomes cash. Weigh these beside the note, not against the number.
Screener's own checklist not mine, not the score
In its favour
- Company has reduced debt.
- Company is almost debt free.
- Company has a good return on equity (ROE) track record: 3 Years ROE 89.6%
- Company has been maintaining a healthy dividend payout of 75.4%
Against it
- Stock is trading at 51.7 times its book value
Generated by screener.in from a fixed checklist — not written by me and not an input to the score. It is here as a second machine opinion to weigh against the note; where it disagrees with the view above, the note is the considered one.